MDSS EUROPEAN AUTHORIZED REPRESENTATIVE SERVICES MDSS CONSULTING   ENGLISH    GERMAN    CHINESE

Get a Quote from MDSS Your Authorized Representative forMedical Devices and In Vitro Diagnostic Devices

News Updates
  • Looking for a suitable GMDN-Code?
    MDSS can assist you to determine an appropriate code for your products!
    more


  • Have MDSS, your Authorized Representative, apply for a Free Sales Certificate/Certificate of Marketability on your behalf! more


  • Cosmetic Products in Europe
    Latest News


    
HIGHLIGHTS
Keep up to date!

News and Views June 2017

News and Views May 2017 - Latest Update


In-House Workshops
The "NEW CE" mark
Book now!
to make sure you’re ready to survive and thrive




EVENTS
Meet us!

RAPS
September 09-12, 2017
National Harbor, MD, USA
Booth #537



Join us!

RAPS Twin Cities Chapter
September 07, 2017
Minneapolis-Saint Paul, USA
(more details coming soon)

RMD 2017 Europe
06-07 October, 2017
Berlin, Germany


MDSS Workshops (MDR)

End October, 2017
East Coast, USA




Contact MDSS

MDSS GmbH
Schiffgraben 41
30175 Hannover
Germany

Phone
(+49)-511-6262 8630
FAX
(+49) -511-6262 8633

Click here to
contact us





MDR & IVDR – Companies must act


The EU Regulations for medical devices and in-vitro-diagnostics are casting their shadows.

During the past years, several scandals involving medical devices caused European committees to radically revise the former directives 93/42/EEC and 90/385/EEC and to adapt them to current technical standards. A so-called Medical Device Regulation (MDR) became binding this year, with a 3-year transition period.

In particular, quality and safety requirements for medical engineering companies and associated services have been intensified. Key changes concern, among other things, the conduct of clinical studies (e.g. in regards to clinical evaluation), the labeling of medical devices (UDI, among others) as well as a stricter control of manufacturers (increased number of audits or conducting of unannounced audits).

Regarding In-vitro-diagnostic devices, Directive 98/79/ EC has also been revised and is available as a draft. The introduction of the In-Vitro-Diagnostic Regulation (IVDR) is also planned for 2017 and will become binding with a 5-year transition period. Both European regulations are legislative acts and set a high safety standard for patients and users. The goal is the assurance of a homogenous and well-functioning EU internal market, taking into consideration the infrastructure of smaller and medium-sized medical device manufacturers.

MDSS GmbH will analyse  with you your existing documentation and demonstrate  to what extent you must become active in order to fulfil the new requirements.
Based on a gap analysis we will identify the discrepancies between the actual state within your organization and the target criteria of the legal requirements of the MDR or IVDR - while maintaining your present company policy.

We will be happy to guide you though these times of regulatory challenge. Please do not hesitate to contact us!


Read the new EU Regulations here [pdf]: